Mind Medicine Names Schond Greenway as Financial Chief >MNMD

By Colin Kellaher

Mind Medicine (MindMed) Inc. named Schond Greenway as chief financial officer, the New York clinical-stage biopharmaceutical company said Monday.

Mr. Greenway most recently served as chief financial officer of Avalo Therapeutics Inc., which announced his departure in February.

Mind Medicine in March said it had hired an executive search firm to assist in identifying a new chief financial officer after David Guebert retired.

Write to Colin Kellaher at colin.kellaher@wsj.com

Read more…